Cite
MLA Citation
Vikas Dembla et al.. “Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors.” Scientific reports, vol. 7, no. 1, 2017, pp. 1–9. http://access.bl.uk/ark:/81055/vdc_100086863642.0x000129